Delivery Order SPE2DB20D3103-SPE2DB25FQ2F8
Award Date 9/9/25
Potential Completion Date 9/30/25
Potential Value $38K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $38,169.00 to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Cabenuva ER 600 mg-900 mg suspension in 6 mL quantities. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the pharmaceutical distributor's corporate office. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of CABENUVA ER (cabotegravir/rilpivirine) 600 mg-900 mg suspension in 6 mL vials, valued at $38,169.00. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The contract has an ultimate completion date of October 3, 2025, and will be performed at the awardee's location in...
- The Defense Logistics Agency awarded a delivery order valued at $22,901.40 to AmerisourceBergen Drug Corp for CABENUVA ER 600 mg-900 mg suspension in 6 ml quantities. This is a firm fixed price, competitively awarded delivery order with an ultimate completion date of August 15, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and represents a child order under a larger contracting vehicle. No set-aside designation was applied to this...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $45,802.80 on August 1, 2025, for the supply of CABENUVA ER 600 mg-900 mg suspension in 6 mL units. This firm fixed-price delivery order, which has no set-aside designation, is scheduled for completion by August 22, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a competitive procurement action under the company's...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $30,535.20 fixed-price delivery order is for the supply of CABENUVA ER 600 MG-900 MG SUSP 6ML, a medication used in the treatment of HIV. The contract has an ultimate completion date of April 28, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- The Defense Logistics Agency awarded a $59,619.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for CABENUVA ER 400 MG-600 MG suspension (4 mL), a long-acting injectable antiretroviral medication. The contract, issued on August 29, 2025, with ultimate completion by September 22, 2025, represents a non-competitive, non-set-aside award leveraging the vendor's existing DLA contract vehicle. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- This is a $22,820.10 delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of CABENUVA ER 600 MG-900 MG SUSP 6ML, a pharmaceutical product, with a completion date of June 3, 2024. The contract was competitively awarded and is a firm fixed-price type. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $3,816.90 to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Cabenuva ER 600 mg-900 mg suspension (6 mL). This competitively awarded, non-set-aside contract utilizes firm fixed pricing and calls for completion by August 28, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in Conshohocken, PA...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $30,535.20 to AmerisourceBergen Drug Corp for CABENUVA ER 600 MG-900 MG suspension (6 mL), a long-acting antiretroviral combination medication used in HIV treatment. Issued on September 14, 2025, with an ultimate completion date of October 3, 2025, this firm fixed-price delivery order represents a routine pharmaceutical procurement under a competitive award with no set-aside designation. The product will be delivered to...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $38,033.50, is for the delivery of CABENUVA ER 600 MG-900 MG SUSP 6ML, a pharmaceutical product. The contract is a delivery order with a firm fixed price, with a completion date of December 10, 2024. This contract does not have a set-aside designation, indicating open competition. AmerisourceBergen...